Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years.

ABSTRACT:

SUBMITTER: Repka MX 

PROVIDER: S-EPMC3137458 | biostudies-literature | 2010 Sep

REPOSITORIES: biostudies-literature